findmyKOL

Hemender Vats, MD

Basic profile

Marshfield Clinic

ORCIDNone on fileNPI
RegionKansas City, MO · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Hemender Vats is a Nephrology physician affiliated with Marshfield Clinic. OpenAlex indexes 22 publications with 501 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
22publications

Distinct works indexed by OpenAlex.

501citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
20companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6400 Prospect Ave
Suite 480
Kansas City, MO 641321100

Telephone

816-276-1700

Registry record last updated 31 Jul 2012.

View the NPPES registry record

Industry payments

20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    60.8%
    Loop diuretic17.7%
    Torsemide63%Furosemide37%
    Part D40 patients
    Beta blocker8.9%
    Carvedilol85%Metoprolol Succinate16%
    Part D<11 patients

    + 10 more classes in this area

  • Metabolism & gastrointestinal

    19.1%
    SGLT2 inhibitor4.4%
    Jardiance67%Farxiga33%
    Part D<11 patients
    Vitamin D3 Analog4.4%
    Calcitriol100%
    Part D16 patients

    + 5 more classes in this area

  • Other

    7.4%
    Phosphate Binder5.3%
    Sevelamer Carbonate100%
    Part D23 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia2.1%
    Velphoro58%Lanthanum Carbonate42%
    Part D<11 patients
Where care is delivered (Part B)59.5% facility · 40.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

17 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”